| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating | 
|---|---|---|---|---|---|---|
| Shell | 0.82% | $84.81M | $218.67B | 15.20% | 73 Outperform | |
| Roche Holding AG | 0.73% | $75.50M | CHF208.68B | 3.85% | 73 Outperform | |
| ASML Holding | 0.72% | $74.84M | $407.86B | 53.91% | 81 Outperform | |
| HSBC Holdings | 0.72% | $74.31M | $243.82B | 52.48% | 78 Outperform | |
| Celestica | 0.64% | $66.20M | $38.96B | 384.05% | 73 Outperform | |
| Rheinmetall | 0.63% | $65.81M | €79.42B | 260.07% | 60 Neutral | |
| Novartis | 0.62% | $64.71M | $234.55B | 10.82% | 73 Outperform | |
| SAFRAN SA | 0.60% | $62.29M | €126.53B | 44.93% | 67 Neutral | |
| Toyota Motor | 0.56% | $57.79M | $268.82B | 18.20% | 70 Outperform | |
| UBS Group AG | 0.52% | $53.82M | $122.05B | 22.10% | ― |